About
Pauline is an associate in Freshfields' IP/commercial team in Singapore, advising clients on business-critical intellectual property, technology and data transactions. She is committed to helping clients realise their technological and business innovations through practical, commercially focused advice.
She is particularly active in the technology, media and telecommunications (TMT), life sciences, consumer, financial services and industrial technology sectors, supporting clients on complex commercial arrangements. These include the development, protection, licensing and commercialisation of IP, technology and data; joint ventures and collaborations; pharmaceutical research, development and commercialisation agreements; and outsourcing and technology procurement and implementation. Pauline also works closely with our M&A teams on the technology, data and IP aspects of corporate transactions.
Before focusing on transactional work, Pauline worked on antitrust and internal investigations for large technology and pharmaceutical companies. She has also practised in New York and Shanghai, before moving to Singapore.
Connect
VCARD
IP, technology and data
- an Indian conglomerate on entering into various long-term and high-value technology licences and related EPC agreements relating to the commercialisation of battery technologies*
- a Chinese conglomerate in relation to entering into long-term and high-value technology licensing agreements, relating to the commercialisation of various battery technologies*
- an Asia-based digital bank on the out-licensing of its digital banking technology and the provision of related services*
- a US headquartered food and beverage business on the divestment of a retail brand in China, including the negotiation of a long-term and high-value brand licence, product supply agreement, and asset purchase agreement relating to the brand and related assets*
- a global ride-hailing business in relation to the potential regulatory issues that could arise in relation to the expanding its platform across various Southeast Asia jurisdictions*
- multiple private equity firms and multinational clients on the IP aspects of corporate and M&A transactions, including due diligence, IP restructuring, the drafting and negotiation of IP-related representations, covenants and closing conditions in acquisition agreements, and geopolitical and export-control risk management in transactions involving Chinese entities*
Life Sciences + Healthcare
- Dr Reddy's Laboratories on the acquisition of a nicotine replacement therapy business from Haleon for GBP500m*
- Fosun on entering into global licensing, development and commercialisation agreements with multiple pharmaceutical companies, relating to the in- and out-licensing of various pharmaceutical assets*
- an RTW Investments-backed Chinese biopharma on entering into multiple exclusive licensing, development and commercialisation agreement with US based pharmaceutical companies*
- a Johnson & Johnson pharmaceutical subsidiary on entering into a licensing agreement with a contract development and manufacturing organisation, relating to the in-licensing of a proprietary viral vector manufacturing platform for use in the client's gene therapy programmes*
- a Hong Kong-listed biopharma on entering into a global exclusive licensing agreement with Singapore's Experimental Drug Development Centre (EDDC), relating to the in-licensing of a series of antiviral compounds*
- a Nasdaq-listed biopharma on entering into a strategic licensing, development and commercialisation collaboration with Pfizer, relating to the in-licensing of Pfizer's respiratory disease therapeutic candidate for development and commercialisation in Greater China and Singapore*
- a China-based digital health company on entering into a strategic partnership and exclusive licensing agreement with a UK-based cognitive science company, relating to the in-licensing of a suite of cognitive assessment and digital brain health tools for commercialisation in China*
*Experience prior to joining Freshfields
Pauline Tang
2 Central Boulevard
#48-01 West Tower, IOI Central Boulevard Towers
Singapore 018916